Role of the Kupffer cell in hepatic carcinogenesis in patients infected with hepatitis C virus

库普弗细胞在丙型肝炎病毒感染者肝癌发生中的作用

基本信息

  • 批准号:
    13671293
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

The number of Kupffer cells increased in the liver with hepatitis C virus infection. Alternatively, IL-18 is a pro-inflammatory cytokine and also a strong enhancer of anti-tumor immune system by activating lymphocytes. Since, IL-18 is predominantly produced by macrophage and the Kupffer cell is a predominant cell population of macrophages in the liver. Therefore, relationship between serum IL-18 level and population of the Kupffer cell in HCV infected patients with or without HCC was investigated.Chronic liver disease (CLD) patients with anti-HCV antibody including chronic hepatitis and liver cirrhosis, patients bearing HCV related HCC, and healthy HCV negative subjects were included in this study. Serum IL-18, IL-12 levels were measured by ELISA. Messenger RNA expression of IL-1 and interferon (IFN)-γ was measured in the liver tissue by RT-PCR. Immunohistochemistry using IL-18 and CD68 anti-macrophage antibodies were performed in the liver. Moreover, oxidative stress marker 8-OHdG, HNE was assessed by immunohistochemistry and immuno-blotting in the liver.Serum IL-18 and IL-12 level in CLD patients was significantly greater than other groups. Messenger RNA expression of Th1 cytokines was increased in the CLD patients. Immunohistochemistry was revealed that IL-18 positive cell was morphologically identified as the Kupffer cell. The number of CD68 positive cell was positively correlated with serum IL-18 levels and 8-OHdG expressions in the liver. Furthermore, after curative treatment of HCC, the disease free survival was significantly poor in the high IL-18 of 8-OHdG group.In conclusion, increases in the number of the Kupffer cell and serum IL-18 levels could be involved in the progression of HCC. Furthermore, serum IL-18 level is practical to predict the high-risk group of HCC occurrence.
丙型肝炎病毒感染者肝脏枯否细胞数量增加。或者,IL-18是促炎细胞因子,也是通过激活淋巴细胞的抗肿瘤免疫系统的强增强剂。因为,IL-18主要由巨噬细胞产生,并且枯否细胞是肝脏中巨噬细胞的主要细胞群。因此,本研究旨在探讨血清IL-18水平与HCV感染伴或不伴HCC患者枯否细胞数量的关系,包括抗HCV抗体阳性的慢性肝病(CLD)患者(包括慢性肝炎和肝硬化)、HCV相关性HCC患者和HCV阴性的健康受试者。ELISA法检测血清IL-18、IL-12水平。RT-PCR检测肝组织中IL-1和IFN-γ mRNA的表达。在肝脏中使用IL-18和CD 68抗巨噬细胞抗体进行免疫组织化学。免疫组化和免疫印迹法检测肝组织中氧化应激标志物8-OHdG、HNE水平,CLD患者血清IL-18和IL-12水平显著高于其他各组。CLD患者Th 1细胞因子的mRNA表达增加。免疫组化显示IL-18阳性细胞为枯否细胞。CD 68阳性细胞数与血清IL-18水平及肝脏8-OHdG表达呈正相关。肝癌患者经治疗后,高IL-18水平的8-OHdG组患者无病生存率明显低于对照组,提示Kupffer细胞数量和血清IL-18水平的升高可能参与了肝癌的进展。血清IL-18水平对预测肝癌高危人群有一定的实用价值。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Akira Maki, Hiroshi Kono, et al.: "Decreased CD3 ζ molecules of T lymphocytes from patients with hepatocellular carcinoma associated with hepatitis C virus"Hepatology Research. (In press). (2003)
Akira Maki、Hiroshi Kono 等人:“与丙型肝炎病毒相关的肝细胞癌患者的 T 淋巴细胞 CD3 分子减少”《肝病学研究》(2003 年出版)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Asakawa, M., and Kono, H., et al.: "Significance of serum interleukin-18 level as predictor of hepatocellular carcinoma in patients with hepatitis C virus"Hepatology Research. (in press). (2003)
Asakawa, M. 和 Kono, H. 等人:“血清白细胞介素 18 水平作为丙型肝炎病毒患者肝细胞癌预测因子的意义”肝病学研究。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KONO Hiroshi其他文献

KONO Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KONO Hiroshi', 18)}}的其他基金

Effects of PACAP on sptic peritonitis
PACAP对脓毒症腹膜炎的疗效
  • 批准号:
    17K10508
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of zirconia implant fixture with guided bone regeneration ability
具有引导骨再生能力的氧化锆种植体夹具的开发
  • 批准号:
    24592960
  • 财政年份:
    2012
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Automatic Generation of CG Lip Movements Based on Individuals Face
根据人脸自动生成CG嘴唇动作
  • 批准号:
    23700260
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Investigation of relationship between the liver and spleen via the portal circulation in sepsis
脓毒症门脉循环肝脾关系的探讨
  • 批准号:
    21591745
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of zirconia complex for metal free restoration
用于无金属修复的氧化锆复合物的开发
  • 批准号:
    21791911
  • 财政年份:
    2009
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Investigation of organ interaction in the innate immune system during inflammation
炎症期间先天免疫系统中器官相互作用的研究
  • 批准号:
    19591579
  • 财政年份:
    2007
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Investigation of heterogeneity of tissue macrophages and inflammatory immune response during infection.
感染过程中组织巨噬细胞异质性和炎症免疫反应的研究。
  • 批准号:
    15591394
  • 财政年份:
    2003
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

A novel treatment for REBOA complications: Hydrogen gas inhalation therapy to alleviate oxidative stress due to ischemia-reperfusion injury
REBOA并发症的新型治疗方法:氢气吸入疗法减轻缺血再灌注损伤引起的氧化应激
  • 批准号:
    23K21458
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Oxidative Stress and Mitochondrial Dysfunction in Chemogenetic Heart Failure
化学遗传性心力衰竭中的氧化应激和线粒体功能障碍
  • 批准号:
    10643012
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
LRRK2 and oxidative stress in Parkinson’s disease
LRRK2 与帕金森病的氧化应激
  • 批准号:
    10799999
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Developing trimester-specific placenta organ-on-chips to model healthy and oxidative stress and inflammation-associated pathologies
开发妊娠期特异性胎盘器官芯片来模拟健康和氧化应激以及炎症相关的病理学
  • 批准号:
    10732666
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
IntBIO: Collaborative Research: Integrating nanobiotechnologies to understand the role of nitro-oxidative stress in the coral-dinoflagellate mutualistic symbiosis dynamics
IntBIO:合作研究:整合纳米生物技术来了解硝基氧化应激在珊瑚-甲藻互利共生动态中的作用
  • 批准号:
    2316389
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Standard Grant
Investigation of the effects of macrolide antimicrobial agents on oxidative stress tolerance in trophoblast cells
大环内酯类抗菌药物对滋养层细胞氧化应激耐受性影响的研究
  • 批准号:
    23K08863
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Determining the role of Rac1 palmitoylation in cardiac hypertrophy and oxidative stress
确定 Rac1 棕榈酰化在心脏肥大和氧化应激中的作用
  • 批准号:
    10534386
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Placental identified NHIP regulating neuronal oxidative stress in autism
胎盘发现 NHIP 调节自闭症神经元氧化应激
  • 批准号:
    10717990
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
The role of oxidative stress in reduced microvascular function after gestational diabetes
氧化应激在妊娠糖尿病后微血管功能下降中的作用
  • 批准号:
    10712433
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Structural systems biology of microenvironmental oxidative stress and synthetic biology intervention
微环境氧化应激的结构系统生物学与合成生物学干预
  • 批准号:
    10715112
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了